Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe (HTx)
The overall objective of HTx is to create a framework for next generation Health Technology Assessment that supports patient-centred, societally oriented, real-time decision-making for integrated healthcare throughout Europe.
The mission of HTx is to facilitate the development of methodologies to deliver more customized information on the effectiveness and cost-effectiveness of complex and personalised combinations of health technologies. HTx will also provide methods to support personalised treatment advice that will be shared with patients and their physicians.
HTx aims also to work in close collaboration with the European Network for HTA (EUnetHTA) and its stakeholders to pilot the implementation of these methods in Europe.
HTx has a life span of 60 months, operating from 2019 to 2023, and a budget of €9,6M distributed across a total of 15 partners including academia, universities, patient associations, SME’s, regulatory authorities and National Health Institutes. The consortium is led by Utrecht University (The Netherlands).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the call BETTER HEALTH AND CARE, ECONOMIC GROWTH AND SUSTAINABLE HEALTH SYSTEMS (Grant Agreement nº 825162).